Clinical trial
Analysis of Mechanism of Resistance to Chemotherapy by Sequencing of Plasma DNA
NCT01930474 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Mechanism of Resistance to Chemotherapy by Sequencing of Plasma DNA
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- Not reported
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer patients